Table S1.
Antigen | Manufacturer and catalog no. | Concentration | Postfix | Protocol |
ASCL1/MASH1 | BD Pharmingen 556604 | 1:1,000 | None | A |
Cleaved caspase 3 | Cell Signaling 9664 | 1:500 | None | C |
INSM1 | Birchmeier laboratory guinea pig serum | 1:20,000 | None | A |
KDM1A/LSD1 | Abcam ab17721 | 1:200 | None | A |
MAP2 | Millipore MAB3418 | 1:500 | Overnight | A |
MKI67/Ki67 | Abcam ab16667 | 1:100 | Overnight | C |
NKX2-1 | Santa Cruz Biotechnology sc-13040 | 1:500 | None | B |
OLIG2 | Chemicon AB9610 | 1:500 | Either | C |
RCOR1 | Neuromab clone K72/8 | 1:200 | None | C |
RCOR2 | Rosenfeld laboratory rabbit serum | 1:10,000 | None | A |
Slides were prepared for blocking in one of three ways. In protocol A, sections were incubated with PBS containing 0.1% TritonX-100 (PBS-Triton) for 30 min. In protocol B, slides were incubated in –20 °C acetone for 10 min, dipped in deionized water, and incubated in PBS for 5 min. Protocol C consisted of protocol B followed by treatment with 10 mM sodium citrate tribasic dihydrate containing 0.1% Tween-20, pH 6.0, for 40 min in an Aroma kitchen steamer.